May 11th 2021, 4:00pm
A woman with metastatic breast cancer describes the overwhelming dread she feels every time she must wait to hear the results of a tumor marker test.
May 3rd 2021, 9:00pm
Olympic volleyball player, April Ross, explained in an interview with CURE® that seeing her mother’s dedication to her family, despite her diagnosis, helped put things into perspective and taught her what is truly important in life.
May 3rd 2021, 1:00pm
Each month, we take a look back at the most popular CURE® stories. Here are the top five stories for April 2021.
April 3rd 2021, 6:00pm
A person with metastatic breast cancer writes about how she just wants to be “normal” again and for people to stop pitying her.
March 30th 2021, 4:00pm
A patient with metastatic cancer writes about how the unknowns of her disease have shaped her life and health experiences, and how she has learned to live with that uncertainty.
March 30th 2021, 12:00pm
Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, and Sara A. Hurvitz, M.D., discuss treatment approaches and modifications during the COVID-19 pandemic.
Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, discusses the learning curve of taking an oral medication, tucatinib, in combination with chemotherapy, and Sara A. Hurvitz, M.D., reviews methods for medication adherence.
Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, discusses how her quality of life has been since she began taking tucatinib with chemotherapy.
Sara A. Hurvitz, M.D., reviews the advances in HER2+ metastatic breast cancer that have been made over the past decade.
Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, shares her goals of treatment after progression of disease.
Better Prostate Cancer Screening for Younger African American Men May Improve Outcomes
Two-Drug Combo Shows Modest Benefit in Biliary Tract Cancer
Novel 4-Drug Combo Significantly Improves Treatment Responses in Group of Patients with Breast Cancer
How Does a Patient with Cancer Nominate One Nurse?
